Clinical Trial Update: Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors [Phase 1]

View source ↗

Summary

This update notes that ISM6331 is being studied in a Phase 1 trial with recruitment ongoing for participants with malignant mesothelioma and other advanced/meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Mesothelioma
• Malignant Solid Tumor

Drugs mentioned

• ISM6331

Snippet

Sponsor: InSilico Medicine Hong Kong Limited | Conditions: Malignant Mesothelioma, Metastatic Malignant Solid Tumor | Phase 1 | Status: RECRUITING